We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Protein Toxins Help Anthrax Avoid Immune System

By Biotechdaily staff writers
Posted on 10 Sep 2002
In a recent study, researchers found a protein complex (lethal toxin, or LT) produced by Bacillus anthracis, the bacteria that causes anthrax, that is able to inhibit and destroy macrophages, the immune system's primary defense against such pathogens. The study was published August 29, 2002, in the online journal Science Express.

Instead of being destroyed by the immune system, the anthrax bacteria survive and germinate within the macrophages and travel with them throughout the body to the lymph nodes, and eventually into the bloodstream, ultimately leading to fatal systemic shock if treatment fails.

The investigators, from the University of California, San Diego (UCSD, USA), looked for the mechanism used by the bacteria to evade destruction by the macrophages. They found that the bacteria manufacture a number of proteins that work together to disrupt macrophage function.

Another protein, called protective antigen (PA), binds to the cell surface and allows bacterial proteins to penetrate the macrophage. These proteins, termed lethal factor (LF), cleave and disable specific protein kinases (called mitogen activated protein kinase kinases, or MKKs) that play a vital role in activation of the p38 protein kinase, whose enzymatic activity is essential for survival of the macrophage. The authors of the current study believe that PA and LF function together in the form of LT, which inhibits p38. Inactivation of p38 leads to the death of the macrophage and prevents secretion of the chemokines and cytokines that would alert the immune system to the presence of an invading pathogen.

Dr. Michael Karin, professor of pharmacology at UCSD and the study's senior author, explained that anthrax and other deadly pathogens, such as bubonic plague, take several days or up to a week for symptoms to appear, as the body's normal immune response has been subdued. "We have wondered why this bug does not make patients sick early on, especially since it does not take many bacteria to make us sick. Feeling sick is actually good. It means we are fighting the effects of infection with a fever or runny nose. Not being sick means your immune system is not detecting the infection.”



Related Links:
U. of California, San Diego

New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
New
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
New
Prefilled Tubes
Prefilled 5.0ml Tubes
New
All-in-One Molecular System
AIO M160

Latest BioResearch News

Study Identifies Protein Changes Driving Immunotherapy Resistance in Multiple Myeloma
10 Sep 2002  |   BioResearch

Genetic Analysis Identifies BRCA-Linked Risks Across Multiple Cancers
10 Sep 2002  |   BioResearch

Study Identifies Hidden B-Cell Mutations in Autoimmune Disease
10 Sep 2002  |   BioResearch